Frontiers in nephrology: Early atherosclerosis - A view beyond the lumen

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Endothelial dysfunction is an established clinical marker of early coronary artery disease and has been shown to be associated with increased cardiovascular morbidity and mortality. New concepts now extend the view of endothelial dysfunction beyond the traditional involvement of the coronary arterial endothelium alone. Recent research indicates that the coronary vessel wall, especially the vasa vasorum, as well as bone marrow-derived endothelial progenitor cells may be subject to proatherosclerotic changes, even before the development of angiographically evident endothelial dysfunction; therefore, "microvascular endothelial dysfunction," which is composed of dysfunction of the vasa vasorum's endothelium as well as "microcellular endothelial dysfunction," reflecting impaired mobilization and function of endothelial progenitor cells, may precede "macrovascular endothelial dysfunction." Vasa vasorum neovascularization, with endothelial leakage and dysfunction increasing influx of proinflammatory and proatherogenic cellular and noncellular substances into the vessel wall, is proposed as one feature of this new concept. In addition, the role of bone marrow-derived endothelial progenitor cells is discussed as are the potential impact of impaired progenitor cell mobilization, release from the marrow, and function in acute and stable coronary artery disease. Finally, potential future therapies are proposed, focusing on interventions that may prevent or diminish the development of the microvascular and microcellular endothelial dysfunction.

Original languageEnglish (US)
Pages (from-to)2836-2842
Number of pages7
JournalJournal of the American Society of Nephrology
Volume18
Issue number11
DOIs
StatePublished - Nov 2007

Fingerprint

Vasa Vasorum
Nephrology
Atherosclerosis
Bone Marrow
Endothelium
Coronary Artery Disease
Coronary Vessels
Stem Cells
Biomarkers
Morbidity
Mortality
Research
Endothelial Progenitor Cells
Therapeutics

ASJC Scopus subject areas

  • Nephrology

Cite this

Frontiers in nephrology : Early atherosclerosis - A view beyond the lumen. / Gossl, Mario; Lerman, Lilach O; Lerman, Amir.

In: Journal of the American Society of Nephrology, Vol. 18, No. 11, 11.2007, p. 2836-2842.

Research output: Contribution to journalArticle

@article{c1e5f7f5940c4def85ca16ac1f2f3d99,
title = "Frontiers in nephrology: Early atherosclerosis - A view beyond the lumen",
abstract = "Endothelial dysfunction is an established clinical marker of early coronary artery disease and has been shown to be associated with increased cardiovascular morbidity and mortality. New concepts now extend the view of endothelial dysfunction beyond the traditional involvement of the coronary arterial endothelium alone. Recent research indicates that the coronary vessel wall, especially the vasa vasorum, as well as bone marrow-derived endothelial progenitor cells may be subject to proatherosclerotic changes, even before the development of angiographically evident endothelial dysfunction; therefore, {"}microvascular endothelial dysfunction,{"} which is composed of dysfunction of the vasa vasorum's endothelium as well as {"}microcellular endothelial dysfunction,{"} reflecting impaired mobilization and function of endothelial progenitor cells, may precede {"}macrovascular endothelial dysfunction.{"} Vasa vasorum neovascularization, with endothelial leakage and dysfunction increasing influx of proinflammatory and proatherogenic cellular and noncellular substances into the vessel wall, is proposed as one feature of this new concept. In addition, the role of bone marrow-derived endothelial progenitor cells is discussed as are the potential impact of impaired progenitor cell mobilization, release from the marrow, and function in acute and stable coronary artery disease. Finally, potential future therapies are proposed, focusing on interventions that may prevent or diminish the development of the microvascular and microcellular endothelial dysfunction.",
author = "Mario Gossl and Lerman, {Lilach O} and Amir Lerman",
year = "2007",
month = "11",
doi = "10.1681/ASN.2007030333",
language = "English (US)",
volume = "18",
pages = "2836--2842",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "11",

}

TY - JOUR

T1 - Frontiers in nephrology

T2 - Early atherosclerosis - A view beyond the lumen

AU - Gossl, Mario

AU - Lerman, Lilach O

AU - Lerman, Amir

PY - 2007/11

Y1 - 2007/11

N2 - Endothelial dysfunction is an established clinical marker of early coronary artery disease and has been shown to be associated with increased cardiovascular morbidity and mortality. New concepts now extend the view of endothelial dysfunction beyond the traditional involvement of the coronary arterial endothelium alone. Recent research indicates that the coronary vessel wall, especially the vasa vasorum, as well as bone marrow-derived endothelial progenitor cells may be subject to proatherosclerotic changes, even before the development of angiographically evident endothelial dysfunction; therefore, "microvascular endothelial dysfunction," which is composed of dysfunction of the vasa vasorum's endothelium as well as "microcellular endothelial dysfunction," reflecting impaired mobilization and function of endothelial progenitor cells, may precede "macrovascular endothelial dysfunction." Vasa vasorum neovascularization, with endothelial leakage and dysfunction increasing influx of proinflammatory and proatherogenic cellular and noncellular substances into the vessel wall, is proposed as one feature of this new concept. In addition, the role of bone marrow-derived endothelial progenitor cells is discussed as are the potential impact of impaired progenitor cell mobilization, release from the marrow, and function in acute and stable coronary artery disease. Finally, potential future therapies are proposed, focusing on interventions that may prevent or diminish the development of the microvascular and microcellular endothelial dysfunction.

AB - Endothelial dysfunction is an established clinical marker of early coronary artery disease and has been shown to be associated with increased cardiovascular morbidity and mortality. New concepts now extend the view of endothelial dysfunction beyond the traditional involvement of the coronary arterial endothelium alone. Recent research indicates that the coronary vessel wall, especially the vasa vasorum, as well as bone marrow-derived endothelial progenitor cells may be subject to proatherosclerotic changes, even before the development of angiographically evident endothelial dysfunction; therefore, "microvascular endothelial dysfunction," which is composed of dysfunction of the vasa vasorum's endothelium as well as "microcellular endothelial dysfunction," reflecting impaired mobilization and function of endothelial progenitor cells, may precede "macrovascular endothelial dysfunction." Vasa vasorum neovascularization, with endothelial leakage and dysfunction increasing influx of proinflammatory and proatherogenic cellular and noncellular substances into the vessel wall, is proposed as one feature of this new concept. In addition, the role of bone marrow-derived endothelial progenitor cells is discussed as are the potential impact of impaired progenitor cell mobilization, release from the marrow, and function in acute and stable coronary artery disease. Finally, potential future therapies are proposed, focusing on interventions that may prevent or diminish the development of the microvascular and microcellular endothelial dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=35848965917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35848965917&partnerID=8YFLogxK

U2 - 10.1681/ASN.2007030333

DO - 10.1681/ASN.2007030333

M3 - Article

C2 - 17928505

AN - SCOPUS:35848965917

VL - 18

SP - 2836

EP - 2842

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 11

ER -